Physician profile
Faiza Waheed Butt
NPI 1578948790
$18,159.69
in general payments reported to CMS, 2019-2025
17 companies · $26.94 in 2025
The $26.94 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $1,730 · 2021: $454 · 2022: $850 · 2023: $407 · 2024: $449 · 2025: $26.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $852 · Travel and Lodging: $31.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $851.69 |
| Travel and Lodging | $31.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $11,057.04 | 2019-2024 | |
| Medtronic USA, INC. | $4,653.77 | 2019-2020 | |
| Medtronic, INC. | $1,112.32 | 2021-2024 | |
| Abbott Laboratories | $245.16 | 2021-2023 | Infinity |
| Acadia Pharmaceuticals INC | $207.02 | 2020-2023 | Nuplazid |
| Abbvie INC. | $177.81 | 2019-2025 | Botox |
| Insightec,INC | $165.10 | 2023 | Exablate |
| Teva Pharmaceuticals USA, INC. | $133.15 | 2019 | |
| Kyowa Kirin, INC. | $124.77 | 2020 | |
| Allergan, INC. | $64.83 | 2021 | |
| Baxter Healthcare | $54.82 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Merz Pharmaceuticals, LLC | $45.21 | 2021-2022 | |
| Merz North America, INC. | $30.89 | 2019 | |
| Acorda Therapeutics, INC | $25.81 | 2019 | |
| Argenx US, INC. | $24.46 | 2024 | Vyvgart Hytrulo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tanabe Pharma America, INC. | $24.06 | 2024 | |
| Amneal Pharmaceuticals LLC | $13.47 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Faiza Waheed Butt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.